Poxvirus immune evasion strategies (360G-Wellcome-090315_B_09_A)

£2,216,660

The objectives of this research are to understand how vaccinia virus, the prototypical poxvirus, suppresses the host innate immune response to infection, and how this impacts on virus virulence and the adaptive immune response that follows. This investigation will provide fundamental information about the host-pathogen interactions, how the innate immune response functions and influences the adaptive response, how the innate immune system can be inhibited, and how this information can be used to develop more immunogenic and safer poxvirus-based vaccines. It is also a goal to obtain co-crystal structures of the vaccinia virus proteins with their cellular binding partners to understand in molecular detail how inhibition of the innate immune system is mediated and in the long term to use this information to develop small molecule inhibitors of innate immunity that will have anti-inflammatory therapeutic value.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 2216660
Applicant Surname Smith
Approval Committee Science Interview Panel
Award Date 2014-07-08T00:00:00+00:00
Financial Year 2013/14
Grant Programme: Title Principal Research Fellowship Programme
Internal ID 090315/B/09/A
Lead Applicant Prof Geoffrey Smith
Partnership Value 2216660
Planned Dates: End Date 2019-12-31T00:00:00+00:00
Planned Dates: Start Date 2015-01-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East of England
Sponsor(s) Prof Duncan Maskell